Researchers assessed a new approach to paying for cancer drugs in England’s National Health Service based on achieved outcomes. Their findings may help to improve patient access to medicines and ensure value for the NHS.
An exploration and review of international evidence around best practices in organisational design for research funding bodies has helped to inform the design of the umbrella organisation UK Research and Innovation (UKRI). The research also contributed to decisions around governance structures and strategy.
To ensure the continued excellence of the UK’s research and innovation (R&I) base, the existence and continuity of funding is key. Additionally, numerous interacting conditions are needed to translate research and stimulate innovation, but there is no ‘magic formula’ for these conditions to be implemented.
Economic analyses offer a compelling case for the benefits that research and innovation (R&I) can deliver, but R&I also offers numerous benefits that are either not easily monetised or not well understood. These include benefits to culture, public engagement, social cohesion and the environment.
Ammonia emissions in the UK have been rising since 2013, largely due to agricultural waste and fertiliser runoff. By 2020 the impacts on biodiversity, ecosystems, and human health may total over £700 million per year.
RAND Europe and the University of Cambridge tested whether the Q Improvement Lab approach could become an effective, valuable way of developing ideas or interventions to support positive change at multiple levels of the health and care system.
Stakeholders and 'customers' say the Eastern Academic Health Science Network's TSU—which helps implement innovative solutions to challenges faced by health and care providers—has supported them with their pilots and network building. An evaluation provides recommendations for further improvements.
To inform the development of the guidance and criteria for the preparation of impact case studies in Research Excellence Framework (REF) 2021, we examined the case studies submitted to REF 2014 and identified quantitative indicators of impact. We then developed guidance for how these indicators could be standardised for potential use in REF 2021.
The Canadian Institutes of Health Research asked RAND Europe to update the 2009 study on grant peer review to provide a more widely applicable source of evidence around the strengths and weaknesses of peer review for grant funding assessment.
Through a rapid review of the available literature and interviews with four experts, researchers compiled a practical overview of crowdsourcing in citizen science. The report highlights the benefits of crowdsourcing, best tools to use, and best practices.
EU-funded research and development into poverty-related and neglected diseases has had a significant impact on strengthening research capacity in low- and middle-income countries, but its effects on encouraging universal health coverage is less clear.
Industry, governments and academics are all speculating on the ways in which blockchain could revolutionize everything from finance to the music industry. Now is the time for policymakers and industry to take note and find out what blockchain could offer.
Driverless cars could be tested on Britain’s roads by 2021. While this is likely to be great news to many, the race is now on for policymaking to catch up. Why? Because driverless cars could substantially change more than just the way people travel.
The SBRI Healthcare programme is viewed as providing effective support for small companies to develop innovations that address NHS needs. Because some businesses have asked for more support taking innovations to the NHS, Academic Health Science Networks need clear guidance about how they could support SBRI-supported companies.